ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

ClinicalTrials.gov ID: NCT05031780

Public ClinicalTrials.gov record NCT05031780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 12:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease

Study identification

NCT ID
NCT05031780
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Agios Pharmaceuticals, Inc.
Industry
Enrollment
286 participants

Conditions and interventions

Interventions

  • Mitapivat Drug
  • Mitapivat-matching placebo Other

Drug · Other

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 10, 2022
Primary completion
Oct 29, 2025
Completion
Jan 31, 2030
Last update posted
Apr 22, 2026

2022 – 2030

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
University of California San Diego La Jolla California 92037-1337
UCLA Health Los Angeles California 90095-1678
Children's Hospital Oakland Oakland California 94609
University of Connecticut Health Center Farmington Connecticut 06030-0001
Children's National Hospital Washington D.C. District of Columbia 20010-2916
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
Sylvester Comprehensive Cancer Center-Miami Miami Florida 33101
University of Chicago Medical Center Chicago Illinois 60637-1443
Riley Hospital For Children Indianapolis Indiana 46202-5109
LSU Health Sciences Center - Shreveport Shreveport Louisiana 71103-4228
National Heart Lung and Blood Institute Bethesda Maryland 20814
Kaiser Permanente - Largo Medical Center Largo Maryland 20774-5374
Massachusetts General Hospital Boston Massachusetts 02114-2621
Boston Children's Hospital Boston Massachusetts 02115-5724
Boston Medical Center & Boston University School of Medicine Boston Massachusetts 02118
University of Michigan Ann Arbor Michigan 48109-5000
Children's Hospital of Michigan Detroit Michigan 48201
Southern Specialty Clinic Flowood Mississippi 39232
Mississippi Center for Advanced Medicine Madison Mississippi 39110-6115
Cure 4 The Kids Foundation, A Division of Roseman University of Health Sciences Las Vegas Nevada 89106
East Carolina University - Brody School of Medicine Greenville North Carolina 27834
Penn Medicine - University of Pennsylvania Health System Philadelphia Pennsylvania 19104-5127
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134-1011
Lifespan at Rhode Island Hospital Providence Rhode Island 02903
University of Texas Health Science Center of Houston Houston Texas 77030-1501
Texas Children's Hospital Houston Texas 77030
Virginia Commonwealth University Richmond Virginia 23298-5058
Seattle Cancer Care Alliance, University of Washington Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05031780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05031780 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →